Nanotechnology Based On Management of Glaucoma: Review

Nanotechnology has transformed medical disciplines, creating tools and materials for molecular control and repair of human biological systems. It can improve ocular bioavailability and drug residence in glaucoma treatment, increase surgical success, and minimize postoperative scarring. Further research is needed to fully understand nanotechnology’s therapeutic effects. The purpose of this review is to compile the research on nanotechnology advancements, with a focus on ocular devices used to treat. Glaucoma is a leading cause of blindness, affecting the delicate human eye. Traditional eye therapies, such as implants, eye drops, and injections, face complications due to low bioavailability or adverse effects. Nanoscience technology offers a novel approach to ocular disease treatment, modifying active molecules to react with nanocarriers. This review explores nanotechnology’s therapeutic and diagnostic prospects in ophthalmology, specifically glaucoma, focusing on efficiency, safety, and potential applications in glaucoma.